Press Release

29.01.2018

New clinical study on iXip

The new clinical study on iXip "PSAIgM2017" has been approved at the Spedali Civili hospital in Brescia, Italy.

The prospective and multicenter study will analyze the correlation between the index iXip and the definitive histological exam in patients who underwent radical prostatectomy.

The study is registered on the ClinicalTrials.gov website with the ID code: NCT03413007.